SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-23-006066
Filing Date
2023-12-28
Accepted
2023-12-28 16:30:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 BIODEXA PHARMACEUTICALS PLC p23-3084sc13g.htm SC 13G 112044
2 JOINT FILING AGREEMENT p23-3084exhibit99.htm EX-99.1 10878
  Complete submission text file 0000902664-23-006066.txt   124604
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Subject) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89366 | Film No.: 231523032
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 82 EAST ALLENDALE ROAD, SUITE 5B SADDLE RIVER NJ 07458
Business Address 82 EAST ALLENDALE ROAD, SUITE 5B SADDLE RIVER NJ 07458 201-391-1839
Cavalry Fund I LP (Filed by) CIK: 0001677197 (see all company filings)

IRS No.: 464484680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G